Clinical trials with exogenous interferon: summary of a meeting.
about
Effect of antiviral agents on replication of herpes simplex virus type 1 in brain culturesCombined antiviral effect of interferon and acyclovir on herpes simplex virus types 1 and 2Synergistic antiviral activity of acyclovir and interferon on human cytomegalovirusMechanisms of fever induced by recombinant human interferon.Duration of effect of interferon aerosol prophylaxis of vesicular stomatitis virus infection in mice.Interferon aerosol suppression of vesicular stomatitis virus replication in the lungs of infected mice.Combined protective effects on interferon and interferon induction on herpes simplex and ectromelia virus infections in micePulmonary deposition and clearance of aerosolized interferonDifferent effects of influenza virus, respiratory syncytial virus, and Sendai virus on human lymphocytes and macrophages.Replacement of animal serum proteins by human albumin for growth and interferon production by Namalva cells.Selective antiviral activity of human interferons on primate oncogenic and neurotropic herpesviruses.Interferon therapy: pharmacokinetic and pharmacological aspects.Differences between human alpha (leukocyte) and beta (fibroblast) interferons.Antiviral agents: an update--Part 2.The human interferon system.Interferon--present and future prospects.Augmentation of endotoxin fever by recombinant human beta interferon in rabbits.Psychosocial factors and recurrent genital herpes: a review of prediction and psychiatric treatment studies.
P2860
Q28360513-14385027-6DBE-4624-BF45-4EBB907DD107Q28365847-E1028605-6BA1-4006-AFE0-3EEC94F56063Q28366289-AE36866D-073A-412C-A25B-5051F2A79A60Q34614028-8D4F80FB-C471-4337-9490-F8737629C66AQ35568897-A7677FC0-BA24-49F5-B26E-3419BFA4E006Q35639896-2FF3AC8C-92B9-4045-BAF4-590B73B948F7Q35670046-6BC27C1C-E2E9-4FB0-93D6-2540DB3F55C1Q35760678-A655D009-0BBB-49F6-883F-4A80B693AC5AQ36438241-7F8CEB52-AAB1-4E18-AC70-473F631F8CF9Q36487765-FF552E79-9A80-4DD6-9F48-4B18028D682DQ36589835-1CD2DA38-68C2-45E7-9119-FEC95C87391AQ40099867-C8104CDA-260C-4AC7-A005-8CEA5B425DE5Q40100330-15B4C823-7AD8-49A1-B903-15243E433CA8Q40100907-A967B9F3-6BC4-4384-84EE-6A4D8CF6A57AQ40102632-C8B6048E-6B7A-476F-BCE6-2DDA11E435F0Q40109995-9DED8709-2B09-47AD-9970-36B2FD5F82F5Q40163116-F06242E6-B595-49FB-B490-BA3B79C2651FQ40839973-80ED3893-97B6-4B2C-9F21-A3CBD0EFF193
P2860
Clinical trials with exogenous interferon: summary of a meeting.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Clinical trials with exogenous interferon: summary of a meeting.
@en
Clinical trials with exogenous interferon: summary of a meeting.
@nl
type
label
Clinical trials with exogenous interferon: summary of a meeting.
@en
Clinical trials with exogenous interferon: summary of a meeting.
@nl
prefLabel
Clinical trials with exogenous interferon: summary of a meeting.
@en
Clinical trials with exogenous interferon: summary of a meeting.
@nl
P356
P1476
Clinical trials with exogenous interferon: summary of a meeting.
@en
P2093
Dunnick JK
Galasso GJ
P304
P356
10.1093/INFDIS/139.1.109
P407
P577
1979-01-01T00:00:00Z